$79.74 -0.97 (%) Eli Lilly & Co - New York Stock Exchange, Inc.

Sep. 29, 2016 | 04:00 PM

Partner Headlines

  1. Biotech Lilly Upgraded On Alzheimer's Drug's $7.5 Billion Potential

    IBD | Sep. 27, 2016 | 16:25PM EST
  2. Biosimilars In Limelight On FDA Approval Of Amgen Drug

    TalkMarkets | Sep. 27, 2016 | 13:30PM EST
  3. Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to Buy Abbott's AMO

    TalkMarkets | Sep. 23, 2016 | 13:15PM EST
  4. Southern Company Leads 52 Stocks Going Ex-Dividend Next Week

    Dividend.com | Aug. 4, 2016 | 08:00AM EST
  5. Biogen Stock Pops As Merck, Allergan Reportedly Probing Buyout

    Investors Business Daily | Aug. 2, 2016 | 15:49PM EST
  6. AbbVie, Merck Beat Earnings Estimates, But Sanofi Lags

    Investors Business Daily | Jul. 29, 2016 | 10:46AM EST
  7. Alder Biopharma Migraine Drug Holds Up After 6 Months

    Investors Business Daily | Jul. 25, 2016 | 11:05AM EST
  8. Lilly, J&J, Novo Battle For Diabetes Market Heats Up; FDA Rulings Loom

    Investors Business Daily | Jul. 22, 2016 | 10:44AM EST
  9. Top Funds Heart Edward Lifesciences, Bump Lilly

    IBD | Feb. 5, 2016 | 14:27PM EST
  10. Merck Stock Slides As Q4 Revenue, Guidance Miss Expectations

    IBD | Feb. 3, 2016 | 11:44AM EST
  11. Earnings Recap For January 28

    Benzinga | Jan. 28, 2016 | 16:34PM EST
  12. Eli Lilly Punished For Inline Report

    Benzinga | Jan. 28, 2016 | 11:34AM EST
  13. JNJ Kicks Off Health Care Earnings—What About Deals, Buybacks?

    Benzinga | Jan. 25, 2016 | 11:43AM EST
  14. Stock Marquee Crowded With Oil, Apple, and the Fed

    Benzinga | Jan. 25, 2016 | 10:25AM EST
  15. Last-Hour Rally Erases Midday Losses As Indexes Close Mixed

    IBD | Jan. 19, 2016 | 16:49PM EST
  16. Steven Cohen Makes Eli Lilly, Kraft Heinz Top New Buys

    GuruFocus | Jan. 7, 2016 | 13:14PM EST
  17. A Calmer Year For Pharma?

    IBD | Jan. 6, 2016 | 18:47PM EST
  18. 3 Potential Blockbuster Drugs Launching in 2016

    IBD | Jan. 6, 2016 | 09:42AM EST
  19. Lilly Counts On Pipeline In '16

    IBD | Jan. 5, 2016 | 18:56PM EST
  20. Lilly Guidance Misses Estimates On Lower Sales

    IBD | Jan. 5, 2016 | 13:18PM EST
  21. The 5 Top-Performing Big-Cap Drug Stocks Of 2015

    IBD | Dec. 30, 2015 | 14:16PM EST
  22. 5 Top Stocks of the Outperforming Vanguard Health Care Fund

    GuruFocus | Dec. 24, 2015 | 15:44PM EST
  23. Mairs and Power Sells Baxalta, Walt Disney, Target

    GuruFocus | Dec. 16, 2015 | 16:08PM EST
  24. Strategic Beta ETFs Among Year's Top Performers

    IBD | Dec. 15, 2015 | 19:12PM EST
  25. Benzinga's Top Upgrades

    Benzinga | Dec. 7, 2015 | 08:59AM EST
  26. GoPro PT Cut; Chipotle, Bluebird Bio Downgraded

    IBD | Dec. 7, 2015 | 08:56AM EST
  27. Cautious Stock Rebound as Jobs Data Delivers But Wages Still in Question

    Benzinga | Dec. 4, 2015 | 10:46AM EST
  28. Lilly Ends Basal Insulin Peglispro Development Program

    Benzinga | Dec. 4, 2015 | 08:00AM EST
  29. HOTCHKIS & WILEY Buys More Than 7 Million Shares in Oil and Gas Company

    GuruFocus | Dec. 2, 2015 | 18:44PM EST
  30. Merck

    IBD | Dec. 1, 2015 | 18:47PM EST
  31. 3 Big Pharma Upgrades (And One Downgrade) At Barclays

    IBD | Dec. 1, 2015 | 15:31PM EST
  32. Amazon's PT Raised; Yum, J&J, Merck, Lilly Upgraded

    IBD | Dec. 1, 2015 | 09:15AM EST
  33. Benzinga's Top Upgrades

    Benzinga | Dec. 1, 2015 | 08:55AM EST
  34. Sanofi Chipping Away At Biogen's MS Dominance

    IBD | Nov. 30, 2015 | 11:32AM EST
  35. Steven Cohen Hikes Stake in Microsoft by More Than 50,000%

    GuruFocus | Nov. 27, 2015 | 18:01PM EST
  36. Biotechs Weaken, But These Names Have Bullish Charts

    IBD | Nov. 25, 2015 | 17:19PM EST
  37. Eli Lilly Release Confirms FDA Approval If Portrazza

    Benzinga | Nov. 24, 2015 | 14:44PM EST
  38. Lilly and Merck Expand Immuno-oncology Collaboration with Phase III Nonsquamous Non-Small Cell Lung Cancer Trial

    Benzinga | Nov. 19, 2015 | 06:33AM EST
  39. Goldman Sachs' Top 4 Smid-Cap Biotech Picks

    IBD | Nov. 18, 2015 | 15:36PM EST
  40. PRIMECAP Sells Stake in Technology Company

    GuruFocus | Nov. 16, 2015 | 17:04PM EST
  41. Benzinga's Top Upgrades

    Benzinga | Nov. 16, 2015 | 08:54AM EST
  42. ELI LILLY

    IBD | Nov. 10, 2015 | 18:47PM EST
  43. Lilly, Incyte Announce Data Demonstrate Baricitinib Superiority to Adalimumab in Improving Signs and Symptoms of RA

    Benzinga | Nov. 7, 2015 | 20:04PM EST
  44. DOJ Eyes Lilly, Merck Pricing

    IBD | Nov. 6, 2015 | 18:57PM EST
  45. How This Top Stock Mutual Fund Manager Seeks Growth

    IBD | Nov. 4, 2015 | 18:43PM EST
  46. How This Top Stock Mutual Fund Manager Seeks Growth

    IBD | Nov. 3, 2015 | 18:43PM EST
  47. Sanofi, Novo Nordisk Slide On Diabetes Headwinds

    IBD | Oct. 29, 2015 | 12:40PM EST
  48. Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase 3 Data

    Benzinga | Oct. 27, 2015 | 13:20PM EST
  49. Eli Lilly Q3 Earnings, Guidance Beat On Cost Control

    IBD | Oct. 22, 2015 | 12:36PM EST
  50. Eli Lilly CEO: Our Drug Prices are Fair

    FoxBusiness | Oct. 22, 2015 | 10:28AM EST
Trading Center